GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » aap Implantate AG (LTS:0N5A) » Definitions » EV-to-EBITDA

aap Implantate AG (LTS:0N5A) EV-to-EBITDA : -9.18 (As of Jun. 04, 2024)


View and export this data going back to 2010. Start your Free Trial

What is aap Implantate AG EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, aap Implantate AG's enterprise value is €12.99 Mil. aap Implantate AG's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was €-1.42 Mil. Therefore, aap Implantate AG's EV-to-EBITDA for today is -9.18.

The historical rank and industry rank for aap Implantate AG's EV-to-EBITDA or its related term are showing as below:

LTS:0N5A' s EV-to-EBITDA Range Over the Past 10 Years
Min: -41.97   Med: -4.05   Max: 13.23
Current: -9.18

During the past 13 years, the highest EV-to-EBITDA of aap Implantate AG was 13.23. The lowest was -41.97. And the median was -4.05.

LTS:0N5A's EV-to-EBITDA is ranked worse than
100% of 484 companies
in the Medical Devices & Instruments industry
Industry Median: 16.125 vs LTS:0N5A: -9.18

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-04), aap Implantate AG's stock price is €2.73216. aap Implantate AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.290. Therefore, aap Implantate AG's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


aap Implantate AG EV-to-EBITDA Historical Data

The historical data trend for aap Implantate AG's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

aap Implantate AG EV-to-EBITDA Chart

aap Implantate AG Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -4.41 -1.59 -2.46 -35.71 -7.43

aap Implantate AG Semi-Annual Data
Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58.76 -35.71 - -7.43 -

Competitive Comparison of aap Implantate AG's EV-to-EBITDA

For the Medical Devices subindustry, aap Implantate AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


aap Implantate AG's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, aap Implantate AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where aap Implantate AG's EV-to-EBITDA falls into.



aap Implantate AG EV-to-EBITDA Calculation

aap Implantate AG's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=12.987/-1.415
=-9.18

aap Implantate AG's current Enterprise Value is €12.99 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. aap Implantate AG's EBITDA for the trailing twelve months (TTM) ended in Jun. 2023 was €-1.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


aap Implantate AG  (LTS:0N5A) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

aap Implantate AG's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=2.73216/-0.290
=At Loss

aap Implantate AG's share price for today is €2.73216.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. aap Implantate AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €-0.290.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


aap Implantate AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of aap Implantate AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


aap Implantate AG (LTS:0N5A) Business Description

Traded in Other Exchanges
Address
Lorenzweg 5, Berlin, DEU, 12099
aap Implantate AG develops, manufactures, and markets trauma products for orthopedics. The company classifies its products that are Trauma and Others. The product line of the company consists of a plating system under the brand LOQTEQ, and cannulated screws. The company's projects such as antibacterial silver coating technology and magnesium-based implants. It develops a plating system for the Shoulder, Knee, Elbow, Wrist, and Ankle Joint. The company sells its product directly to hospitals, syndicates, and hospital groups with the help of distributors.

aap Implantate AG (LTS:0N5A) Headlines

No Headlines